Follow on Google News News By Tag * Ino * Rnn * Ampe * Gain * Growth * Simon Says Stocks * Penny Stock * Biopharmaceutical * Pharmacy * Drugs * Disease * Cure * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | INO, RNN, AMPE-Late Afternoon Biopharmaceutical Picks-source: SimonSaysStocks.comINO, RNN, AMPE-Late Afternoon Biopharmaceutical Picks. SimonSaysStocks.com provides you with the most up-to-date penny stock alerts, Join now for more free penny stock alerts.
By: Editorial Staff Inovio Pharmaceuticals Inc , focusing on cancer and infectious diseases, is a company involved in the exploration and development of their DNA delivery technology. INO, last at $1.12 a share, uses their technology to amplify the body’s ability to take biopharmaceuticals. Trading between $1.10 and $1.16, INO experienced an increase of 5.7% and a gain of +0.06 early this afternoon. Rexahn Pharmaceuticals Inc , a clinical stage company, was last at $1.78 a share. RNN focuses on finding cures for cancer and central nervous system related disorders. Rexahn, last trading between $1.45 and $1.91, released news stating that their products Zoraxel and Serdaxin are close to deals with pharmaceutical companies. RNN was last at an increase of 23.9% and a gain of +0.34. Ampio Pharmaceuticals Inc is a Delaware corporation engaged in the development of drugs to cure diseases like Metabolic disease and kidney disease. AMPE, up 17.5% and at a gain of +0.35, has two products being developed (Optina and Vasaloc) for diabetic related diseases. Ampio was last trading at $2.35 a share in the early afternoon. About SimonSaysStocks.com SimonSaysStocks.com is an independent electronic publication that provides information on selected publicly traded companies. SimonSaysStocks.com is not a registered investment advisor or broker-dealer. SimonSaysStocks.com’ End
Account Email Address Disclaimer Report Abuse
|
|